gliconorm
Gliconorm™ is a film-coated, divisible tablet which contains a fixed dose of glibenclamide (5 mg) and metformin (500 mg).
| Name | Gliconorm |
| Description | Gliconorm™ is a second line therapy to treat non-insulin dependent diabetes mellitus (NIDDM). This fixed dose in one tablet provides convenience for patients and helps increase patient compliance. |
| Active substance | Glibenclamide, Metformin. |
| Indication | Gliconorm™ is a second line therapy to treat non-insulin dependent diabetes mellitus (NIDDM) that cannot be satisfactorily controlled with diet alone, diet plus a sulfonylurea, or diet plus metformin. |
| Strengths | Glibenclamide 5mg + Metformin 500mg. |
| Regulatory Status | Approved in Italy, last revised: Nov 2007 Approved in Bahrain – 14 Dec 2011 Under registration – Iraq and Kuwait |
| Business Partner | ABIOGEN |
